InventisBio, Co., Ltd. engages in drug research and development focusing on major diseases such as tumors and metabolic diseases. Its drugs have been developed to cover solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as metabolic diseases such as hyperuricemia and gout. The company was founded by Yaolin Wang on January 11, 2013 and is headquartered in Shanghai, China.